"K-Beauty Core Material Export" Daebong LS, Strong Performance in the First Half

[Financial News] Daebong LS, a company specializing in cosmetic materials and active pharmaceutical ingredients, announced on the 18th that its sales in the first half of this year were 52.4 billion won and operating profit was 6 billion won. This represents an increase of 12% and 37%, respectively, compared to the same period last year, improving both growth and profitability.
A representative from Daebong LS explained, "In the global beauty market, the demand for K-materials is rapidly spreading, and in the cosmetics material sector, we have secured a competitive edge with specialized technology in natural-derived high-functionality raw materials, leading to improved performance."
Particularly in the European, North American, and Southeast Asian markets, the eco-friendly, vegan, and upcycle trends are spreading, and △Yuja-derived liposome 'Citronosome' △Natural-like ceramide 'Citron Barrier Ceramide' △Lotus root upcycle extract 'Lotus Root Extract' have received positive responses.
Daebong LS is strengthening its portfolio, covering all product lines from basic bases to peptide actives, based on strategic partnerships with global chemical companies such as BASF and Lubrizol Life Sciences. It is equipped with a system to support technology and supply materials tailored to the needs of various beauty brands domestically and internationally.
Daebong LS is solidifying its position as a high-functionality K-material company optimized for sustainable cosmetic trends amid the diversified flow of the global cosmetics market, such as clean beauty and derma beauty. In the second half of the year, it plans to launch new materials applying skin adhesion technology, enhance product differentiation, and expand exports to major overseas markets such as Europe, North America, and Southeast Asia.
Additionally, it operates a one-stop total solution that supports domestic beauty brands seeking overseas expansion and OEM/ODM companies from the R&D stage to material design and customized raw material provision. Through this, it aims to enhance customer-tailored value and continue diversifying sales.
In the active pharmaceutical ingredient sector, the domestic and international demand for existing main items such as hypertension treatments and respiratory treatments continued to expand, maintaining stable growth. The new salt-based hypertension treatment of the azilsartan family has improved bioavailability and stability compared to existing ones, secured a patent in Japan, and is preparing for commercialization. Major improved new drugs such as epinaconazole co-crystal form, L-eldosteine, and liraglutide are also progressing in development, and the possibility of market entry and export expansion is continuously being explored.
A representative said, "As a result of participating in major global beauty exhibitions in Europe and North America, we were able to achieve tangible results such as expanding overseas clients and diversifying export items in the first half of the year," and added, "In the second half of the year, export expansion is expected based on this trend." He continued, "Through the launch of new materials applying skin adhesion technology, we will further strengthen our technological competitiveness as a K-material specialized company."

butter@fnnews.com Kang Kyung-rae Reporter